生物标志物 生物标志物
Feng Gao1, Yaxi Zhan2, Yong Shen3
1Department of Neurology, Institute on Aging and Brain Disorders, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
像MMP2这样的矩阵金属蛋白酶 (MMPs) 可能会在阿尔茨海默氏症 (AD) 中保护粉样蛋白病理. 在AD患者中,较低的MMP2水平与粉样蛋白和脑血管损伤的增加相关.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 病理学 病理学 病理学
背景情况:
- 阿尔茨海默氏病 (AD) 的发病包括粉样蛋白和脑血管问题.
- 矩阵金属蛋白酶 (MMPs) 对粉样β (Aβ) 降解和脑血管病理都有影响.
- 在AD中MMPs的确切作用尚不清楚,需要进一步调查.
研究的目的:
- 为了研究脑脊液 (CSF) 中MMPs水平和AD中的粉样蛋白和脑血管病理之间的关系.
- 为了澄清MMP2和MMP9在AD进展的具体作用.
主要方法:
- 从CANDI队列中分析了299名参与者 (认知无障碍,MCI,AD,非AD) 的CSF样本.
- 测量脑脊髓中MMP2,MMP9,Aβ38,Aβ40和Aβ42.2的数量.
- 利用结构性MRI,AV45 PET扫描和液体生物标志物 (Qalb,CSF PDGFRβ) 来评估病理.
主要成果:
- 与对照人群相比,MCI和AD患者的CSF MMP2水平显著降低.
- 减少MMP2,而不是MMP9,与较低的CSFAβ水平和较高的Aβ PET SUVR相关.
- 脑脊MMP2和MMP9与脑血管病理 (WMH,CMB,缺口,PVS,Qalb) 有积极的相关性.
- 下CSFMMP2与纵向大脑缩有关.
结论:
- 许多MMP与大脑血管损伤有关.
- 在AD中,MMP2似乎对粉样蛋白病理有保护作用.
- 在AD中临床使用MMP抑制剂应考虑MMP2对粉样蛋白病理学的保护作用.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516